Joel Lexchin MD
Showing all 11 results
| Title & Subtitle | Abstract | Contributors | Pages | Year | Purchase |
|---|---|---|---|---|---|
|
From  Academic health science centresresearch, money, controversies, conflict of interest and independence From: Doctors in Denial |
Describes and analyzes the money received by academic health science centres from the pharmaceutical industry for research and the conflicts that this money may create. | Joel Lexchin MD | 32 | 2017 | $3.20 Add |
|
From Doctors, sales representatives, samples, gifts, trips and dinnersFrom: Doctors in Denial |
Discusses the various forms of interactions that pharmaceutical companies have with individual doctors in Canada, and how this impacts the health care they provide to their patients. | Joel Lexchin MD | 32 | 2017 | $3.20 Add |
|
From Don’t worry, be happy?From: Doctors in Denial |
Discusses whether patient care is negatively affected by the interactions that pharmaceutical companies have with the medical profession. | Joel Lexchin MD | 23 | 2017 | $2.30 Add |
|
From Government, industry and the medical professionménage à trois From: Doctors in Denial |
Describes how the alliance between the medical profession and the pharmaceutical industry developed in the period from the 1960s to 2015. | Joel Lexchin MD | 27 | 2017 | $2.70 Add |
|
From Guidelines on relationships between industry and the medical professiona guide to salvation? From: Doctors in Denial |
Discusses the development of ethical guidelines regarding the pharmaceutical industry by medical organizations by five organizations: the Canadian Medical Association, the College of Physicians … | Joel Lexchin MD | 39 | 2017 | $3.90 Add |
|
From IntroductionDoctors in denial: welcome to the comfort zone From: Doctors in Denial |
Provides an overview of the medical industry in Canada paying particular attention to the influence of the pharmaceutical industry. Outlines and examines critically the different opinions … | Joel Lexchin MD | 14 | 2017 | $1.40 Add |
|
From Key opinion leaders, clinical practice guidelines and medical societiesgetting the message out From: Doctors in Denial |
Examines the impact of the conflicts of interest that occur when Canadian researchers and Canadian medical societies rely on pharmaceutical companies for favours, trips, and research funding. | Joel Lexchin MD | 31 | 2017 | $3.10 Add |
|
From Medical journals — advertisements, money, regulation, rebellion and possibly retrenchmentFrom: Doctors in Denial |
Discusses the relationship between medical journals and the pharmaceutical industry. Discusses the push back of medical journals towards the pharmaceutical industry in more recent years and … | Joel Lexchin MD | 37 | 2017 | $3.70 Add |
|
From Medical students and physicians-in-training (residents)get them while they are young From: Doctors in Denial |
Examines the influence of the pharmaceutical industry on medical education in Canada. | Joel Lexchin MD | 28 | 2017 | $2.80 Add |
|
From Medicine and industrya marriage of convenience or a marriage made in heaven? From: Doctors in Denial |
Outlines how the alliance between the pharmaceutical industry and the medical community developed; economics, Medicare and patents were factors. | Joel Lexchin MD | 15 | 2017 | $1.50 Add |
|
From Reforming the comfort zone so that doctors are no longer in denialFrom: Doctors in Denial |
Outlines the needed reforms to the interactions between the pharmaceutical industry and the medical profession, outlining industry’s role, government’s role, and the medical … | Joel Lexchin MD | 45 | 2017 | $4.50 Add |
